Transferrin Ensures Survival of Ovarian Carcinoma Cells Subjected to Deferoxamine, TNFA, FASL, Trail or MYC-Activation
Saved in:
Main Authors: | Sandra Fassl, Georg Rosenberger, Michael Grusch, Gerhard Fuhrmann, Katharina Leuhuber, Doris Polgar, Georg Krupitza |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2001-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2001.192 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CDC25A Mediates Survival by Activating AKT Kinase
by: C. Leisser, et al.
Published: (2001-01-01) -
Investigating the Expression of c-Myc and BIRC5 in TRAIL and PBOX-15 treated Metastatic Prostate Cancer Cells
by: Corinne Kai Leng Chew, et al.
Published: (2024-12-01) -
Deferoxamine Intradermal Delivery Patch for Treatment of a Beta-Thalassemia Wound
by: David Perrault, MD, et al.
Published: (2024-03-01) -
Uptake of Non-Transferrin Iron by Erythroid Cells
by: Eugenia Prus, et al.
Published: (2011-01-01) -
The TRAIL map
by: Jan-Peter Sandler, et al.
Published: (2025-01-01)